Denominazione assente

• Course name: Doctoral Course in Pharmaceutical Sciences
• Course: 41st cycle
• Starting from: 2025–2026
• Board committee:

  Coordinator

  MELI Rosaria

  Components

  AMATO Jussara, BORBONE Nicola, CAROTENUTO Alfonso, CINTI Stefano, CIRINO Giuseppe, CONTE Claudia, D'EMMANUELE DI VILLABIANCA Roberta, ESPOSITO Veronica, FATTORUSSO Caterina, GALDIERO Stefania, GIUSTINIANO Mariateresa, GRIECO Paolo, LAVECCHIA Antonio, MARINELLI Luciana, MELI Rosaria, MINIACI Maria, PAGANO Bruno, RIGANO Daniela, ROSSI Antonietta, ROVIEZZO Fiorentina, RUSSO Roberto, SEPE Valentina, SEVERINO Beatrice, UNGARO Francesca, VELLECCO Valentina, ZAMPELLA Angela

  Didactic Commission 

  MELI Rosaria (coordinator), GALDIERO Stefania, PAGANO Bruno, RUSSO Roberto, SEPE Valentina

  Admission Commission

  GRIECO Paolo, MELI Rosaria, ZAMPELLA Angela, LAVECCHIA Antonio (first substitute), CIRINO Giuseppe (second substitute)

• Available positions: 10 (6 of which with fellowship)
• Course length: 3 years
• Course affiliation: Department of Pharmacy
• Useful information:

  List of selected topics for the 41st cycle of the Doctoral Course in Pharmaceutical Science

  Topic	Title	Tutor and co-tutor, special fundings (if indicatede)
  Topic 1	Meta-Inflammation as a driver of multiorgan failure: role of persulfidation	Drs. Bucci Mariarosaria and Cirino Giuseppe
  Topic 2	Identification of Novel Ligands for the Cancer-Related Protein CD44 Using NMR and Other Biophysical Techniques	Drs. Carotenuto Alfonso and Marasco Daniela
  Topic 3	Bioactive plant extracts traditionally used to reduce menopausal disorders: identification, characterisation of the phytocomplex metabolic profile and functional validation	Drs. Daglia Maria and Di Minno Alessandro
  Topic 4	Targeting KRAS isoforms in cancer	Drs. De Simone Alfonso and Ruggiero Alessia
  Topic 5	Harnessing Artificial Intelligence and Advanced Computational Methods to Develop Next-Generation Immune Checkpoint Modulators for Immuno-Oncology	Drs. Di Leva Francesco Saverio and Donati Greta
  Topic 6	Targeting transient α-synuclein aggregates in Parkinson's disease	Drs.Fusco Giuliana and De Simone Alfonso
  Topic 7	Development of Green Synthetic Methodologies for Stable Isotope-labelled Anticancer Drugs	Drs. Giustiniano Mariateresa and Irace Carlo
  Topic 8	Validation of New Models for Endocrine/Immune Risk Assessment	Drs. Grumetto Lucia and Santamaria Rita
  Topic 9	Exploring the role of N-acyl taurines and its synthetising enzyme Bile Acid-CoA:Amino Acid N- Acyltransferase in colorectal cancer carcinogenesis	Drs. Izzo Angelo Antonio and Borrelli Francesca
  Topic 10	Biotechnological development of exosomes for the health and well-being of the skin	Drs. Laneri Sonia and Greco Giovanni
  Topic 11	Development of Nuclear Receptor Modulators for the Treatment of Metabolic Diseases: An Integrated Approach Based on Artificial Intelligence and Molecular Modeling	Drs. Lavecchia Antonio and Greco Giovanni
  Topic 12	Exploring the effects of gut microbiota perturbation on DNA methylation program to control intestinal homeostasis and inflammation	Drs. Lembo Francesca and Buommino Elisabetta
  Topic 13	Evaluation of PEA effect in CNS disease: role of the gut microbiota as pharmacological target	Drs. Mattace Raso Giuseppina and Pirozzi Claudio
  Topic 14	Exploration of the antidiabetic and anti-inflammatory chemical space via marine natural products by Diversity Oriented Synthesis (DOS) and/or Fragment-Based Ligand Drug Discovery (FBLDD) approaches	Drs. Menna Marialuisa and Casertano Marcello
  Topic 15	Advanced data-driven models integrating drug utilization to assess and predict the impact of medication adherence on Health Care System	Drs. Orlando Valentina and Menditto Enrica
  Topic 16	Design of Novel Bioactive Molecules Targeting and/or Mimicking Specific Protein Hot-Spots	Drs. Persico Marco and Fattorusso Caterina
  Topic 17	The aryl hydrocarbon receptor as a therapeutic target in asthma: linking environmental exposure to immune dysregulation	Drs. Roviezzo Fiorentina and Woo Sheridan
  Topic 18	Innovative Systems for Localized Delivery of Anticancer Drugs: From Development to Preclinical Validation	Drs. Sodano Federica and De Stefano Luca
  Topic 19	Soil-Water Interactions and Cyanobacterial Metabolites: From Ecosystem Health to Bioactive Compound Discovery	Drs. Tartaglione Luciana and De Marco Anna
  Topic 20	Development of supramolecular peptide nanosystems for the delivery of new bioinorganic drugs	Drs. Tesauro Diego and Morelli Giancarlo
  Topic 21	New Molecules and Modified Aptamers for Targeting Proteins Involved in Pathological Processes	Drs. Varra Michela and Galeone Aldo